The 340B Drug Program plays a crucial role in providing medication to underserved populations. Given its importance in vulnerable communities, covered entities work diligently to maintain compliance and certification. However, this is not an easy task, and recertification or facing a Health Resources and Services Administration (HRSA) audit can be daunting.